RE:RE:RE:RE:RE:News out on Goblet trial with MerckWow, now 10B would be a dream come true for all but realistically what is wrong with 2-3 billion (20 -30 times our market cap now) and let someone else run the ship. We do not know if someone has actually made a solid real offer or not and onc is not going to tell. Honestly we have biomarkers, successful aware1 data and really all results have been good to date and we have collaborations with a lot of the bigs (as does everyone) so what is the holdup and why no institutions knocking on the door.
Is there something that we are not aware of. Will the bracelet be the be all end all or will be now need something else to confirm. And will onc please tell us if Adalai is using the bio-markers as this is supposedly what all the delays were about. There would be no reason for them not to. simple yes or no question .